U.S. market Closed. Opens in 11 hours 47 minutes

CANF | Can-Fite BioPharma Ltd. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Revenue743.00K810.00K853.00K763.00K2.03M3.82M847.00K170.00K165.00KN/AN/AN/A469.00K745.21K
Cost of Revenue15.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit728.00K810.00K853.00K763.00K2.03M3.82M847.00K170.00K165.00KN/AN/AN/A469.00K745.21K
Operating Expenses8.92M10.91M13.70M14.90M14.04M9.23M8.22M8.80M6.58M7.13MN/AN/A5.27M4.51M
Selling, General & Admin2.94M3.14M3.85M2.95M3.06M3.16M2.96M2.73M2.73M11.57M4.52MN/AN/AN/A
Research & Development5.98M7.76M9.85M11.95M10.98M6.08M5.29M6.08M3.86M16.20M4.42M3.52M3.41M2.82M
Other Operating ExpensesN/AN/AN/AN/AN/AN/A-20.55K-3.64K-3.28K-20.64MN/AN/A1.86M1.69M
Operating Income-8.20M-10.10M-12.84M-14.14M-12.01M-5.41M-7.38M-8.63M5.07M24.52M-8.99M-6.00M-4.80M-3.76M
Other Expenses / Income561.00K-77.00K227.00K-304.00K-618.00K-759.00K12.37M15.66MN/AN/A146.16K148.82K-2.62M152.48K
Before Tax Income-7.63M-10.17M-12.62M-14.44M-12.62M-6.57M4.99M7.02M5.07M24.52M-8.85M-5.86M-7.42M-3.61M
Income Tax Expenses1.0063.00K-20.00K363.00K427.00K4.00KN/AN/AN/AN/A2.58K2.94K50.18K66.23K
Net Income-7.63M-10.24M-12.60M-14.81M-13.05M-6.57M4.99M7.02M5.07M24.52M-8.34M-5.57M-6.70M-3.68M
Interest ExpensesN/A63.00K22.00K363.00K427.00K1.20MN/AN/AN/AN/A16.08K7.23KN/A7.33K
Basic Shares Outstanding4.26M2.72M1.84M1.19M286.37K38.90M10.86M923.67K22.95M17.55M457.07K335.03K347.45K289.57K
Diluted Shares Outstanding4.26M2.72M1.84M1.19M286.37K38.90M10.86M923.67K22.95M17.55M457.07K335.03K347.45K289.57K
EBITDA-8.18M-10.10M-12.84M-14.11M-11.94M-5.36M5.01M7.04M5.08M24.54M-8.81M-5.84M-6.59M-3.53M
EBITDA Margin-1,100.94%-1,246.42%-1,505.51%-1,848.89%-587.70%-140.39%591.84%4,142.62%3,080.24%0.00%0.00%0.00%-1,405.60%-473.07%
EBIT-7.63M-10.11M-12.59M-14.08M-12.20M-5.36M4.99M7.02M5.07M24.52M-8.32M-5.56M-6.65M-3.60M
EBIT Margin-1,027.46%-1,248.15%-1,476.32%-1,845.35%-600.30%-140.39%589.49%4,131.76%3,070.30%0.00%0.00%0.00%-1,417.82%-483.62%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙